title: The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.
abstract: OBJECTIVE
  To introduce and promote the use of long-acting reversible methods of contraception (LARC; intrauterine contraceptives and subdermal implant) by removing financial and knowledge barriers.
  
  
  METHODS
  The Contraceptive CHOICE Project is a prospective cohort study of 10,000 women 14-45 years who want to avoid pregnancy for at least 1 year and are initiating a new form of reversible contraception. Women screened for this study are read a script regarding long-acting reversible methods of contraception to increase awareness of these options. Participants choose their contraceptive method that is provided at no cost. We report the contraceptive choice and baseline characteristics of the first 2500 women enrolled August 2007 through December 2008.
  
  
  RESULTS
  Sixty-seven percent of women enrolled (95% confidence interval, 65.3-69.0) chose long-acting methods. Fifty-six percent selected intrauterine contraception and 11% selected the subdermal implant.
  
  
  CONCLUSIONS
  Once financial barriers were removed and long-acting reversible methods of contraception were introduced to all potential participants as a first-line contraceptive option, two-thirds chose long-acting reversible methods of contraception.
authors.affiliation: Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St Louis School of Medicine, St Louis, MO, USA.
authors.forename: Gina M
authors.initials: GM
authors.lastname: Secura
authors.forename: Jenifer E
authors.initials: JE
authors.lastname: Allsworth
authors.forename: Tessa
authors.initials: T
authors.lastname: Madden
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Mullersman
authors.forename: Jeffrey F
authors.initials: JF
authors.lastname: Peipert
mesh_terms: D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D016001:Confidence Intervals; D003267:Contraception / Q000379:methods* / Q000706:statistics & numerical data; D003268:Contraception Behavior; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000191:economics*; D003274:Contraceptive Devices, Female / Q000191:economics / Q000706:statistics & numerical data; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D004343:Drug Implants / Q000008:administration & dosage / Q000191:economics*; D005193:Family Planning Services / Q000379:methods; D005260:Female; D006801:Humans; D007434:Intrauterine Devices / Q000191:economics* / Q000706:statistics & numerical data; D008875:Middle Aged; D011247:Pregnancy; D011336:Probability; D011446:Prospective Studies; D012307:Risk Factors; D013997:Time Factors; D055815:Young Adult
chemical_list: D003271:Contraceptive Agents, Female; D003692:Delayed-Action Preparations; D004343:Drug Implants